Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. reports recurring developments in outpatient diagnostic imaging, digital health, and radiology technology. The company operates owned and managed imaging centers that provide MRI, CT, PET/CT, mammography, ultrasound, X-ray, fluoroscopy, nuclear medicine, and related procedures for physicians and patients across U.S. markets.
RadNet news commonly covers financial results, imaging-center procedure volumes, guidance updates, joint ventures, acquisitions, and customer or technology collaborations. Its Digital Health segment includes DeepHealth, which provides radiology information technology, AI-powered health informatics, clinical AI applications, patient engagement tools, operational AI, teleradiology services, and related products for the diagnostic imaging industry.
DeepHealth (NASDAQ: RDNT) unveiled at ECR 2026 a cloud-first, integrated portfolio of native clinical AI solutions across MR, CT, X-ray, mammography and ultrasound, plus the acquisition of Gleamer to expand musculoskeletal and X-ray capabilities.
Key validated results include a 21% breast cancer detection increase across 579,000 women, 92% sensitivity for hippocampal atrophy, deployment across >200 RadNet sites with >94% AI measurement acceptance, and AI Studio aggregating >140 algorithms from 75 partners.
RadNet (NASDAQ: RDNT) will present at the Raymond James 47th Annual Institutional Investors Conference in Orlando on Tuesday, March 3, 2026 at 2:15 p.m. ET. Mark Stolper, EVP and Chief Financial Officer, will deliver the presentation.
A live webcast is available and replay-capable via the company's webcast link, and the conference is at the JW Marriott Grande Lakes, Orlando.
RadNet (NASDAQ: RDNT) reported a quarterly record $547.7M revenue and $87.7M Adjusted EBITDA for Q4 2025, increases of 14.8% and 16.9% year-over-year respectively. Full-year 2025 revenue was $2,040.2M with Adjusted EBITDA of $300.2M.
The company reported strong advanced imaging volume growth, Digital Health momentum (Q4 revenue $27.9M), the Gleamer acquisition, and 2026 guidance calling for double-digit revenue and EBITDA growth across segments.
RadNet (NASDAQ: RDNT) acquired Paris-based Gleamer for up to €230 million, integrating it into DeepHealth to create the world’s largest provider of radiology clinical AI solutions.
Gleamer brings ~130 staff, >700 customer contracts in 44 countries, four FDA-cleared and six CE-marked devices, and an expected $30M ARR in 2026 after >90% ARR CAGR (2022–2025). Deployment across RadNet aims for cost and productivity gains by Q3 2026, with focus on X-ray (≈25% of RadNet volume).
DeepHealth (NASDAQ: RDNT) announced that TechLive achieved CE marking on Feb 26, 2026 and is now listed in AWS Marketplace, enabling European commercialization and faster global deployments. TechLive supports MR, CT, PET/CT and ultrasound and is vendor‑agnostic.
Within RadNet, TechLive has connected more than 400 scanners, with reported improvements including a 42% reduction in MR room closure hours and a 27% increase in access to complex procedures. DeepHealth will showcase TechLive at ECR 2026, March 4-8 in Vienna (Booth 506, X5).
RadNet (NASDAQ: RDNT) will host a conference call to discuss its fourth quarter 2025 financial results on Monday, March 2, 2026 at 7:30 a.m. PT / 10:30 a.m. ET. Investors can join by phone or via a simultaneous webcast.
Dial 844-826-3035 (U.S.) or 412-317-5195 (international). Webcast and archived replay details, including replay dial numbers and passcode 10206844, are provided for investor access.
RadNet (NASDAQ: RDNT) acquired the outpatient imaging assets of Northwest Radiology Network, adding six multimodality centers in greater Indianapolis and establishing RadNet's entry into Indiana and the Midwest.
The deal preserves contracted services with 18 Northwest radiologists and is projected to add approximately $18 million of annualized revenue.
RadNet (NASDAQ: RDNT) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 10:30 a.m. PST at The Westin St. Francis Hotel in San Francisco. Presenters include Dr. Howard Berger (President & CEO), Mark Stolper (EVP & CFO), Dr. Gregory Sorensen (EVP & Chief Strategy Officer) and Kees Wesdorp (President & CEO, RadNet Digital Health).
A live webcast is available and offered for replay at the conference webcast link; the company is a national diagnostic imaging provider with 407 owned/operated outpatient imaging centers and over 11,000 team members.
RadNet (NASDAQ: RDNT) has acquired Radiology Regional from LucidHealth, adding 13 imaging centers across Southwest Florida (Naples, Cape Coral, Fort Myers, Port Charlotte, Sarasota).
The deal brings an estimated 400 employees, 44 contracted radiologists and is projected to add approximately $100 million of revenue to RadNet in 2026. Services include MRI, CT, PET/CT, mammography, ultrasound and X-ray.
RadNet said it will deploy its DeepHealth AI portfolio and operational processes to expand access, screening programs and clinical accuracy in the acquired centers.
RadNet (NASDAQ: RDNT) announced the promotion of four senior leaders to expanded executive roles effective January 7, 2026. The changes elevate Stephen Forthuber to President & CEO, Eastern Operations, Norman Hames to President & CEO, Western Operations, Mital Patel to Executive VP & Chief Operating Officer, and Greg Sorensen, M.D., from Chief Science Officer to Chief Strategy Officer while remaining on RadNet’s board.
Company commentary ties the moves to recent record performance across Imaging Center and Digital Health segments and to a strategic focus on moving healthcare toward proactive disease prevention.